Shares of business development company Ares Capital moved into focus after it reported that non-accrual loans increased during the second quarter of 2026. The company said troubled loans rose to 2.4% of its portfolio, up from 1.8% a year earlier, a directionally negative change that still sits below both its long-run average and the broader industry.
For income-focused investors, the key question is whether the rise signals a broader deterioration in borrower health—an issue that can pressure earnings and, over time, dividend coverage. In this update, Ares Capital’s loan-quality metrics improved only modestly, and management’s portfolio-level figures suggest the issue is not yet at an alarm level.
Key takeaways
- Non-accrual loans rose to 2.4% of Ares Capital’s portfolio in the second quarter of 2026, from 1.8% a year earlier.
- Troubled loans increased by 60 basis points year over year, reflecting weaker borrower performance.
- The company’s absolute non-accrual rate remains relatively low versus its own historical range and compared with the BDC industry.
- Investors will be watching for further escalation toward higher historical thresholds, which would raise the risk profile for income.
What drove the move
Ares Capital’s business model depends on the timely repayment of loans made to smaller companies. According to the company’s second-quarter 2026 disclosure, the share of loans classified as non-accrual increased 60 basis points year over year, to 2.4% of the portfolio.
The report also cited an average interest rate of 10.3% paid by clients. That rate level supports returns when borrowers perform, but it can become a liability for weaker businesses during periods of economic stress—particularly for smaller issuers that typically have fewer options for lower-cost refinancing.
In other words, the loan book’s credit performance matters directly for the income investors seek from Ares Capital. If non-accruals continue rising, the company may have less interest income accruing on those loans, potentially tightening coverage for distributions.
Market reaction and what it suggests
Rising non-accruals are generally a negative signal for BDCs because they indicate that more borrowers are failing to meet payment expectations. However, investors typically evaluate non-accrual trends in two ways: the direction of change and the absolute level.
According to the figures cited in the company’s reporting, 2.4% non-accruals remains below Ares Capital’s historical average since the Great Recession, which was described as around 3%. The industry average was described as roughly 4%, putting Ares Capital’s current number in a comparatively stronger position than peers on this specific metric.
As a result, while the increase is not good news, the magnitude appears limited enough that investors may view it as temporary rather than a sign of systemic credit deterioration. The risk, however, is that a continued upward drift could push the portfolio into territory associated with more challenging credit conditions.
Why the absolute number matters now
Credit losses and earnings impacts in BDCs often lag the first signs of borrower stress. That makes early monitoring crucial. Ares Capital’s 60-basis-point year-over-year rise in non-accrual loans should be monitored closely, but the update also provides context for interpreting the change.
The report framed the movement as potentially consistent with “mean reversion,” given that the current non-accrual rate is still beneath the company’s longer-run average and below the industry’s rough benchmark. In practical terms, that means investors may not yet need to assume a broader spread compression or material dividend risk based solely on this quarter’s increment.
Still, the guidance from the comparison is clear: if non-accruals move toward higher levels—such as around the company’s own historical average of about 3% and then continue increasing—investors would likely reassess the credit outlook and the sustainability of income.
What to watch next
Investors in Ares Capital will likely focus on whether non-accrual trends stabilize or accelerate in future quarters. The next signals to monitor include subsequent non-accrual disclosures, any changes in borrower performance that could affect interest income, and management’s outlook for the portfolio as macro conditions evolve. With the company tied to smaller-business credit cycles, upcoming updates around loan performance and credit cost trends will be central to assessing near-term risk to earnings and distributions.
